HCP
54
7
CNP
44
5
MS
69
3
AVB
54
9
AA
47
4
NWS
62
4
EMN
49
3
UHS
58
2
RSG
62
2
AAP
30
3
BBY
45
3
PPL
54
5
OMC
62
3
L
51
5
AEE
55
5
EMR
62
14
K
56
5
BEN
34
6
FOXA
63
3
AKAM
54
3
HCP
54
7
CNP
44
5
MS
69
3
AVB
54
9
AA
47
4
NWS
62
4
EMN
49
3
UHS
58
2
RSG
62
2
AAP
30
3
BBY
45
3
PPL
54
5
OMC
62
3
L
51
5
AEE
55
5
EMR
62
14
K
56
5
BEN
34
6
FOXA
63
3
AKAM
54
3
Financhill
Back

United Therapeutics Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
60

UTHR
United Therapeutics

Last Price:
397.46
Seasonality Move:
4.71%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

United Therapeutics Price Quote

$397.46
+14.69 (+3.84%)
(Updated: November 6, 2024 at 5:55 PM ET)

United Therapeutics Key Stats

Buy
60
United Therapeutics (UTHR) is a Buy
Day range:
$373.03 - $382.95
52-week range:
$208.62 - $382.95
Dividend yield:
0%
P/E ratio:
19.32
P/S ratio:
6.79
P/B ratio:
2.8%
Volume:
277.8K
Avg. volume:
311.6K
1-year change:
70.55%
Market cap:
$17.1B
Revenue:
$2.3B
EPS:
$22.77

How Much Does United Therapeutics Make?

Is United Therapeutics Growing As A Company?

  • What Is United Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.23%
  • What Is United Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.19%

United Therapeutics Stock Price Performance

What Is United Therapeutics 52-Week High & Low?

United Therapeutics Price To Free Cash Flow

Is It Risky To Buy United Therapeutics?

Is United Therapeutics Cash Flow Positive?

  • What Is UTHR Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.1B
  • What Is United Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is United Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $582.5M

United Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    UTHR return on invested capital is 17.45%
  • What Is United Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 16.09%
  • What Is UTHR Return On Equity?
    ROE is a measure of profitability and is 19.26%

United Therapeutics Earnings Date & Stock Price

United Therapeutics Competitors

United Therapeutics Dividend Yield

United Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 18.77% -2.19%
Revenue: 22.89% 3.61%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 382.29
Downside from Last Price: -0.12%

Major Shareholders

  • How many UTHR shares are owned by institutional investors?
    81.4M UTHR shares are owned by institutional investors
  • How many UTHR shares are owned by insiders?
    125.5K UTHR shares are owned by insiders